Aurobindo Pharma expands in Europe
- Details
- Category: Business
Aurobindo Pharma announced that it has recently concluded a strategic deal, for acquisition of Intellectual Property & Marketing Authorizations, with TAD Italy, a generic company registered in Italy. This acquisition will give Aurobindo an access to more than 70 ready to market products which will fast track Aurobindo's entry into the Italian generic market.
GSK charitable support valued at £282 million in 2007
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Zevalin® Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
- Details
- Category: Bayer
![Bayer Bayer](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Genzyme Withdraws Bioenvision's European Filing of Evoltra® in Elderly AML Patients
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
GSK statement on MHRA investigation
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
More Pharma News ...
- Trial Date Set For SEROQUEL® Patent Litigation
- Femara® helps protect against return of breast cancer
- Nycomed intends to move chemical production to Indian joint venture
- Baxter and its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs
- A successful 2007 paves the way for future of Nycomed
- Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
- Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex